Trials / Completed
CompletedNCT00441688
Prospective Epidemiological Study Of The Prevalence Of HLAB*5701 In HIV-1 Infected Patients
Prospective Epidemiological Study of the Prevalence of HLAB*5701 in HIV-1 Infected Patients
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 974 (actual)
- Sponsor
- ViiV Healthcare · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is a cross sectional observational study to evaluate the prevalence of HLA-B\*5701 in the major French ethnotypes. Any HIV-1 infected subject will be eligible for this study including antiretroviral therapy (ART) naÃ-ve and experienced subjects irrespective of abacavir use, as well as subjects previously tested for HLA-B\*5701. Subjects will be approached during a standard clinic visit, and all subjects will be consented prior to any study specific procedure. Subjects will be asked to provide a tissue sample (cheek cells and blood sample) which will be used to assess HLA-B\*5701 status by central and local methodologies.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | GI265235 |
Timeline
- Start date
- 2007-03-15
- Primary completion
- 2007-06-01
- Completion
- 2007-06-01
- First posted
- 2007-03-01
- Last updated
- 2017-08-22
Source: ClinicalTrials.gov record NCT00441688. Inclusion in this directory is not an endorsement.